Approach to congenital heart diseases (cyanotic): Clinical sciences

2,599views

Approach to congenital heart diseases (cyanotic): Clinical sciences

Block 3 CVH

Block 3 CVH

Angina pectoris
Stable angina
Ludwig angina
Unstable angina
Prinzmetal angina
Heart failure
Heart failure: Pathology review
Stroke volume, ejection fraction, and cardiac output
Congestive heart failure: Clinical sciences
Dilated cardiomyopathy
Restrictive cardiomyopathy
Frank-Starling relationship
Myocardial infarction
Acute coronary syndrome: Clinical sciences
ECG cardiac infarction and ischemia
Loop diuretics
Thiazide and thiazide-like diuretics
Potassium sparing diuretics
cGMP mediated smooth muscle vasodilators
ACE inhibitors, ARBs and direct renin inhibitors
Positive inotropic medications
Coronary artery disease: Clinical sciences
Adrenergic antagonists: Beta blockers
Calcium channel blockers
Coronary artery disease: Pathology review
Hereditary spherocytosis
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Approach to anemia (destruction and sequestration): Clinical sciences
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Pyruvate kinase deficiency
Paroxysmal nocturnal hemoglobinuria
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)
Lead poisoning
Oxygen-hemoglobin dissociation curve
Sickle cell disease (NORD)
Sickle cell disease: Clinical sciences
Beta-thalassemia
Beta-thalassemia: Year of the Zebra
Alpha-thalassemia
Mitral valve disease
Valvular heart disease: Pathology review
Valvular insufficiency (regurgitation): Clinical sciences
Abnormal heart sounds
Aortic stenosis: Clinical sciences
Aortic valve disease
Infectious endocarditis: Clinical sciences
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Rheumatic heart disease
Tricuspid valve disease
Pulmonary valve disease
Persistent truncus arteriosus
Transposition of the great vessels
Approach to congenital heart diseases (cyanotic): Clinical sciences
Tetralogy of Fallot
Tetralogy of Fallot: Year of the Zebra
Total anomalous pulmonary venous return
Ventricular septal defect
Approach to congenital heart diseases (acyanotic): Clinical sciences
Atrial septal defect
Patent ductus arteriosus
Acyanotic congenital heart defects: Pathology review
Coarctation of the aorta
Cardiac tumors
Cardiac and vascular tumors: Pathology review
Carcinoid syndrome
Hypertension: Pathology review
Hypertension
Hypertensive emergency
Pulmonary hypertension
Essential hypertension: Clinical sciences
Pulmonary hypertension: Clinical sciences
Approach to hypertension: Clinical sciences
Cor pulmonale
Pulmonary arterial hypertension (NORD)
Cardiomyopathies: Pathology review
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy: Clinical sciences
Cardiac conduction velocity
Cardiac conduction system
ECG cardiac hypertrophy and enlargement
ECG axis
ECG intervals
ECG basics
ECG QRS transition
ECG rate and rhythm
ECG normal sinus rhythm
Atrial fibrillation
Supraventricular arrhythmias: Pathology review
Atrial flutter
Ventricular fibrillation
Ventricular arrhythmias: Pathology review
Atrioventricular block: Clinical sciences
Atrioventricular block
Heart blocks: Pathology review
Long QT syndrome and Torsade de pointes
Brugada syndrome
Pericarditis and pericardial effusion
Pericarditis: Clinical sciences
Recurrent pericarditis (NORD)
Pericardial disease: Pathology review
Cardiac tamponade: Clinical sciences
Myocarditis
Shock
Approach to shock: Clinical sciences
Shock: Pathology review
Iron deficiency and iron deficiency anemia (pediatrics): Clinical sciences
Iron deficiency anemia
Iron deficiency anemia: Clinical sciences
Anemia of chronic disease: Year of the Zebra
Anemia of chronic disease
Folate (Vitamin B9) deficiency
Anemia in pregnancy: Clinical sciences
Vitamin B12 deficiency
Vitamin B12 deficiency: Clinical sciences
Orotic aciduria
Diamond-Blackfan anemia
Sideroblastic anemia
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Acute intermittent porphyria
Porphyria cutanea tarda
Aplastic anemia
Non-hemolytic normocytic anemia: Pathology review
Fanconi anemia
Megaloblastic anemia
Macrocytic anemia: Pathology review
Autoimmune hemolytic anemia
Microcytic anemia: Pathology review
Pernicious anemia: Year of the Zebra
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia (underproduction): Clinical sciences
Epstein-Barr virus (Infectious mononucleosis)
Bartonella henselae (Cat-scratch disease and Bacillary angiomatosis)
Acute leukemia
Approach to leukemia: Clinical sciences
Leukemias: Pathology review
Approach to myeloproliferative neoplasms: Clinical sciences
Chronic leukemia
Myeloproliferative disorders: Pathology review
Non-Hodgkin lymphoma
Lymphomas: Pathology review
Approach to lymphoma: Clinical sciences
Hodgkin lymphoma
Multiple myeloma: Clinical sciences
Multiple myeloma
Waldenstrom macroglobulinemia
Plasma cell disorders: Pathology review
Amyloidosis
Monoclonal gammopathy of undetermined significance
Myelodysplastic syndromes
Approach to myelodysplastic syndromes: Clinical sciences
Polycythemia vera (NORD)
Essential thrombocythemia (NORD)
Myelofibrosis (NORD)
Mastocytosis (NORD)
Langerhans cell histiocytosis
Langerhans cell histiocytosis: Year of the Zebra
Non-steroidal anti-inflammatory drugs
Antiplatelet medications
Anticoagulants: Direct factor inhibitors
Thrombolytics
Anticoagulants: Heparin
Heparin-induced thrombocytopenia
Anticoagulants: Warfarin
Osmotic diuretics
Sympatholytics: Alpha-2 agonists
Sympathomimetics: Direct agonists
Wiskott-Aldrich syndrome
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Premature ventricular contraction
Supraventricular tachycardia: Clinical sciences
Wolff-Parkinson-White syndrome
Anatomy clinical correlates: Heart
Approach to bradycardia: Clinical sciences
Premature atrial contraction
Bundle branch block
Approach to a murmur (pediatrics): Clinical sciences
Approach to cyanosis (newborn): Clinical sciences
Cyanotic congenital heart defects: Pathology review
Williams syndrome
Hypoplastic left heart syndrome
Hypoplastic left heart syndrome: Year of the Zebra 2024
Kawasaki disease
Kawasaki disease: Clinical sciences
Approach to chest pain: Clinical sciences
Ventricular tachycardia: Clinical sciences
Approach to syncope: Clinical sciences
Approach to tachycardia: Clinical sciences
Atrioventricular nodal reentrant tachycardia (AVNRT)
Approach to acid-base disorders: Clinical sciences
Acid-base map and compensatory mechanisms
The role of the kidney in acid-base balance
Acid-base disturbances: Pathology review
Plasma anion gap
Approach to metabolic acidosis: Clinical sciences
Metabolic acidosis
Metabolic alkalosis
Respiratory alkalosis
Approach to metabolic alkalosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Renal tubular acidosis
Respiratory acidosis
Approach to respiratory acidosis: Clinical sciences
Neuroblastoma
Neuroblastoma: Year of the Zebra 2024
Nephroblastoma (Wilms tumor)

Decision-Making Tree

Transcript

Watch video only

Cyanotic congenital heart disease refers to structural heart lesions that cause significant blood oxygen desaturation and cyanosis. Cyanotic congenital heart lesions can be categorized according to their characteristic circulatory patterns, which include increased or decreased pulmonary blood flow, decreased systemic blood flow, or inadequate pulmonary-systemic mixing.

If a pediatric patient presents with a chief concern suggesting cyanotic congenital heart disease, perform an ABCDE assessment. Cyanosis indicates that your patient is unstable, so first stabilize the airway, breathing, and circulation. You may need to intubate and mechanically ventilate your patient. Next, obtain IV access, consider IV fluids, and begin continuous vital sign monitoring, including blood pressure, heart rate, and oxygen saturation. Finally, provide supplemental oxygen, if needed.

Next, obtain a focused history and physical exam, and measure pulse oximetry in the right hand, which measures pre-ductal saturation; and the feet, which measures post-ductal saturation. Pre- and postductal measurements allow you to compare oxygenation of the systemic circulation before and after the ductus arteriosus inserts into the aorta. If pre-ductal saturations are significantly higher than postductal saturations, it means that deoxygenated blood is being shunted from the pulmonary artery to the aorta, through an open ductus arteriosus. This is called differential cyanosis and suggests the presence of critical congenital heart disease.

Okay, you might find a family history of congenital heart disease, or there may have been a prenatal ultrasound demonstrating a heart defect. Exam findings include central cyanosis in areas like the lips and chest. Some patients may display signs of respiratory distress, like dyspnea or tachypnea, as well as a heart murmur or hepatomegaly.

Lastly, pulse oximetry measurements reveal an oxygen saturation below 90% in the right hand and feet, or a saturation below 95% in the right hand and feet on 3 separate occasions. You might also find a 3% difference in saturation between the right hand and foot on 3 separate occasions if the heart lesion is ductal-dependent.

With these findings, consider cyanotic congenital heart disease, so order a chest X-ray and an echocardiogram or echo, and assess the pulmonary and systemic blood flow.

Here’s a clinical pearl! When evaluating a newborn with cyanosis, consider primary lung disease. If echocardiography isn't available, you can use the hyperoxia test to distinguish congenital heart conditions from pulmonary conditions. To do this, obtain arterial blood gases before and after administering 100% oxygen. The PaO2 will rise by 150 mm mercury or more after hyperoxia if the newborn has pulmonary disease, but there will be little to no improvement in cyanotic heart lesions with a right-to-left intracardiac shunt.

Let’s move on to echocardiogram results, starting with patients with increased pulmonary blood flow. In this case, consider mixing lesions like total anomalous pulmonary venous drainage, or TAPVD, with obstruction, and truncus arteriosus.

Newborns with TAPVD with pulmonary venous obstruction develop profound respiratory distress with rapid deterioration. There is usually no murmur on exam but you may detect hepatomegaly. The chest X-ray typically demonstrates severe pulmonary vascular congestion, and the cardiac silhouette might have a "snowman" appearance. An echocardiogram confirms absent venous connections to the left atrium, with the pulmonary veins draining to the right atrium or to the superior or inferior vena cavae, along with obstruction of pulmonary venous drainage. Findings might also demonstrate an enlarged right atrium with a right-to-left shunt through an atrial septal defect, also called ASD, or through a patent foramen ovale, or PFO. These findings confirm TAPVD with obstruction.

Here’s a clinical pearl! Anomalous pulmonary venous return can be either partial, called PAPVD, where 1 or more pulmonary veins return to the left atrium; or total, called TAPVD, where no pulmonary veins return to the left atrium. While TAPVD with obstruction presents in the immediate newborn period with cyanosis and respiratory distress, TAPVD without obstruction may present later, during infancy or childhood, with gradual signs of heart failure and mild- to moderate oxygen desaturation. In contrast, PAPVD is an acyanotic defect that usually manifests in late childhood with signs suggestive of ASD.

Let’s move on to truncus arteriosus. Physical exam typically reveals a hyperdynamic precordium with a single loud S2, and bounding peripheral pulses. Some infants display distinctive facial and physical features suggesting DiGeorge syndrome, such as cleft lip and palate or hypertelorism. Occasionally, cyanosis and signs of heart failure like tachypnea and poor weight gain begin several months after birth. After the first week of life, chest X-ray typically reveals increased pulmonary vascularity, with a prominent ascending aorta, and sometimes, a right-sided aortic arch. Meanwhile, the echo will reveal a single arterial trunk supplying both the systemic and pulmonary circulations, with the truncal artery overlying a ventricular septal defect, or VSD; and a right-to-left shunt through the VSD. These findings confirm truncus arteriosus.

Let’s now discuss decreased pulmonary blood flow. Here, consider lesions like pulmonary atresia with intact ventricular septum, tetralogy of Fallot or TOF, tricuspid atresia, and Ebstein anomaly. Also, start an infusion of prostaglandin E1, or PGE1, to maintain a patent ductus arteriosus.

Here’s a high-yield fact! PGE1 provides a life-saving bridge to surgery in newborns with ductal-dependent lesions by promoting systemic-to-pulmonary mixing or by restoring systemic or pulmonary circulation. Avoid giving PGE1 to infants with increased pulmonary blood flow, since it can exacerbate pulmonary overcirculation.

Sources

  1. "Updated Strategies for Pulse Oximetry Screening for Critical Congenital Heart Disease" Pediatrics (2020)
  2. "Nelson Textbook of Pediatrics, 21st ed." Elsevier (2020)
  3. "Congenital Heart Disease" Pediatr Rev (2017)
  4. "Presentation of congenital heart disease in the neonate and young infant" Pediatr Rev (2007)